Search research articles
Contact Us
Filters
Showing results (21-30 of 71) with videos related to
Page
of 8
Sort By:
Journal of Clinical Lipidology
|
August 12, 2014
Dramatic lowering of very high Lp(a) in response to niacin
Min Li, Ramesh Saeedi, Simon W Rabkin, et al.
BMC Public Health
|
September 12, 2013
Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study
Bonnie McNaughton, Jiri Frohlich, Amy Graham, et al.
ISRN Cardiology
|
April 27, 2012
Predictors of metabolic syndrome in participants of a cardiac rehabilitation program
Alejandra Farias Godoy, Andrew Ignaszewski, Jiri Frohlich, et al.
Lipids in Health and Disease
|
October 11, 2014
Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study
Danijela Gasevic, Jiri Frohlich, Gb John Mancini, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
August 26, 2003
Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification
Jasmine Grewal, Sammy Chan, Jiri Frohlich, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 23, 2004
Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia
Maria Victoria Monsalve, Harvey V Thommasen, George Pachev, et al.
Journal of Lipid Research
|
September 18, 2004
Phenotypic heterogeneity of sitosterolemia
Jian Wang, Tisha Joy, David Mymin, et al.
BMC Clinical Pharmacology
|
October 30, 2008
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Sammy Y Chan, G B John Mancini, Andrew Ignaszewski, et al.
The Canadian Journal of Cardiology
|
September 15, 2006
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease
Ruth McPherson, Jiri Frohlich, George Fodor, et al.
Clinical Chemistry
|
September 6, 2005
Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia
Daniel T Holmes, Brian A Schick, Karin H Humphries, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 71) with videos related to
Sort By:
Page
of 8
Journal of Clinical Lipidology
|
August 12, 2014
Dramatic lowering of very high Lp(a) in response to niacin
Min Li, Ramesh Saeedi, Simon W Rabkin, et al.
BMC Public Health
|
September 12, 2013
Extended interactive voice response telephony (IVR) for relapse prevention after smoking cessation using varenicline and IVR: a pilot study
Bonnie McNaughton, Jiri Frohlich, Amy Graham, et al.
ISRN Cardiology
|
April 27, 2012
Predictors of metabolic syndrome in participants of a cardiac rehabilitation program
Alejandra Farias Godoy, Andrew Ignaszewski, Jiri Frohlich, et al.
Lipids in Health and Disease
|
October 11, 2014
Clinical usefulness of lipid ratios to identify men and women with metabolic syndrome: a cross-sectional study
Danijela Gasevic, Jiri Frohlich, Gb John Mancini, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|
August 26, 2003
Assessment of novel risk factors in patients at low risk for cardiovascular events based on Framingham risk stratification
Jasmine Grewal, Sammy Chan, Jiri Frohlich, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
|
December 23, 2004
Differences in cardiovascular risks in the aboriginal and non-aboriginal people living in Bella Coola, British Columbia
Maria Victoria Monsalve, Harvey V Thommasen, George Pachev, et al.
Journal of Lipid Research
|
September 18, 2004
Phenotypic heterogeneity of sitosterolemia
Jian Wang, Tisha Joy, David Mymin, et al.
BMC Clinical Pharmacology
|
October 30, 2008
Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
Sammy Y Chan, G B John Mancini, Andrew Ignaszewski, et al.
The Canadian Journal of Cardiology
|
September 15, 2006
Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease
Ruth McPherson, Jiri Frohlich, George Fodor, et al.
Clinical Chemistry
|
September 6, 2005
Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia
Daniel T Holmes, Brian A Schick, Karin H Humphries, et al.
Page
of 8